Comparison between Concord Biotech IPO and SBFC Finance IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SBFC Finance IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the SBFC Finance IPO is up to ₹1,025.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of SBFC Finance IPO is ₹57.00 per share.
| Concord Biotech IPO | SBFC Finance IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹54.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹57.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹57.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | ₹2.00 per share |
| Market Lot Size | 20 shares | 260 shares |
| Fresh Issue Size | 0 shares | 10,53,01,883 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹600.09 Cr |
| OFS Issue Size | 2,09,25,652 shares | 7,45,61,402 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹424.91 Cr |
| Issue Size Total | 2,09,25,652 shares | 17,98,63,285 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹1,025.00 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while SBFC Finance IPO opens on Aug 03, 2023. The closing date of Concord Biotech IPO and SBFC Finance IPO is Aug 08, 2023, and Aug 07, 2023, respectively.
| Concord Biotech IPO | SBFC Finance IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Aug 02, 2023 |
| Issue Open | Aug 04, 2023 | Aug 03, 2023 |
| Issue Close | Aug 08, 2023 | Aug 07, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Aug 10, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Aug 11, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Aug 14, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Aug 16, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Sep 09, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Nov 08, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to SBFC Finance IPO P/E ratio of 40.42.
| Concord Biotech IPO | SBFC Finance IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 78.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 64.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 40.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹6065.78 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 9.93% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹1.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 7.97% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in SBFC Finance IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 3,56,05,263 shares in SBFC Finance IPO.
| Concord Biotech IPO | SBFC Finance IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 5,34,07,893 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 3,56,05,263 shares |
| NII | 31,37,348 shares | 2,67,03,948 shares |
| RII | 73,20,479 shares | 6,23,09,210 shares |
| Employee | 10,000 shares | 18,63,636 shares |
| Others | ||
| Total | 2,09,25,652 shares | 17,98,89,950 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas SBFC Finance IPO subscribed 74.06x.
| Concord Biotech IPO | SBFC Finance IPO | |
|---|---|---|
| QIB (times) | 67.67x | 203.61x |
| NII (times) | 16.99x | 51.82x |
| Big NII (times) | 19.30x | 56.69x |
| Small NII (times) | 12.37x | 42.07x |
| RII (times) | 3.78x | 11.60x |
| Employee (times) | 24.48x | 6.21x |
| Other (times) | ||
| Total (times) | 24.87x | 74.06x |
